Adaptive dose painting for prostate cancer
Emil Fredén1, David Tilly2,3, Anders Ahnesjö2
1Department of Oncology, Södersjukhuset, Stockholm, Sweden.
Frontiers in Oncology
|October 14, 2022
Summary
Adaptive radiation therapy (ART) improves dose painting (DP) for prostate cancer, maintaining high tumor control probability (TCP) and avoiding misses seen in conventional workflows.
Area of Science:
- Radiation Oncology
- Medical Physics
- Oncology
Background:
- Dose painting (DP) is a radiation therapy (RT) strategy for heterogeneous tumors, aiming to maximize tumor control by delivering higher doses to resistant regions and lower doses to sensitive ones.
- Spatial accuracy in dose delivery is crucial for DP success, and adaptive RT (ART) workflows can mitigate geometric uncertainties.
Purpose of the Study:
- To dosimetrically compare adaptive RT (ART) and non-adaptive conventional RT workflows for delivering DP prescriptions in prostate cancer (PCa).
Main Methods:
- A planning and treatment simulation study involving four arms: adaptive and conventional workflows with DP and homogeneous dose.
- Utilized MR linac imaging data from 5 PCa patients, with local radiation sensitivity derived from apparent diffusion coefficient maps.
- DP plans were optimized for tumor control probability (TCP) maximization under rectum dose constraints, while homogeneous plans used a range of prostate doses.
Main Results:
- Accumulated DP doses in both adaptive and conventional workflows achieved high TCP (96-99%).
- Adaptive DP showed a marginal advantage over conventional DP (up to 2.6 percentage points).
- Conventional workflows exhibited potential target misses in one patient, which could compromise TCP if systematic.
Conclusions:
- Dose painting (DP) maintains or slightly increases tumor control probability (TCP) compared to homogeneous dosing.
- Adaptive DP workflows effectively avoid target misses, offering an advantage over conventional RT approaches.
More Related Videos
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.5K
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
10.1K
